The Effectiveness of a Caralluma Fimbriata Extract on Stress, Sleep and Neurotransmitters
Clinical trial NCT05232266 · COMPLETED
Trial details
- NCT number
- NCT05232266
- Sponsor
- RDC Clinical Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-10
- Primary completion
- 2023-05-19
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.